PuSH - Publication Server of Helmholtz Zentrum München: Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Blandino, A.* ; Scherer, D.* ; Boekstegers, F.* ; Rounge, T.B.* ; Langseth, H.* ; Roessler, S.* ; Hveem, K.* ; Brenner, H.* ; Pechlivanis, S. ; Waldenberger, M. ; Lorenzo Bermejo, J.*

Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts.

Eur. J. Cancer 214:115138 (2024)

Publ. Version/Full Text

DOI

PMC

	Open Access Gold (Paid Option)

Abstract
Metrics
Extra information

Gallbladder cancer (GBC) is an aggressive disease with limited treatment options but high prevention potential. GBC tumours take 10-20 years to develop, a timeframe that holds potential for early detection. MicroRNAs (miRNAs) play a central role in abnormal cell processes, and circulating miRNAs may constitute valuable biomarkers of early disease. We used microarray data to pre-select differentially expressed miRNAs in formalin-fixed paraffin-embedded (FFPE) gallbladder tissue samples (GBC n = 40, normal n = 8). We then applied small-RNA sequencing to screen for miRNA expression differences in serum samples from three European prospective cohorts (n = 37 GBC case-control pairs), and validated the most promising candidates in three independent cohorts (n = 36 GBC case- control pairs). Statistical analyses included robust linear regression, pathway and meta-analysis, and examination of expression correlation between miRNAs and target genes. MiR-4533 and miR-671-5p were overexpressed in GBC tissue and serum samples, and meta-analysis confirmed the overexpression of miR-4533 in GBC serum samples from the prospective cohorts (p-value = 4.1×10^-4), especially in individuals of female sex, under 63.5 years, or with a BMI below 26.2 kg/m². Pathway and correlation analyses revealed that miR-4533 targets SIPA1L2 in the Rap1 signalling pathway, and SIPA1L2 was downregulated in GBC serum samples. Our study highlights the advantage of integrating small-RNA sequencing results from different types of samples and independent datasets, and the need for international research collaborations to identify and validate biomarkers for secondary prevention of rare tumours such as GBC. The function of miR-4533 and its interaction with SIPA1L2 in GBC development need to be further investigated.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Gallbladder Cancer ; Micrornas ; Molecular Phenotypes ; Prospective Serum Samples ; Serum Biomarkers; Circulating Micrornas; Risk; Signatures; Survival; Genomics; Blood

ISSN (print) / ISBN 0959-8049

e-ISSN 1879-0852

Journal European Journal of Cancer

Quellenangaben Volume: 214, Article Number: 115138

Publisher Elsevier

Publishing Place 125 London Wall, London, England

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Asthma and Allergy Prevention (IAP)
Institute of Epidemiology II (EPI2)

Grants German Academic Exchange Service (DAAD)
European Union
German Research Foundation (DFG)